A third dose of a COVID-19 vaccine boosts the body's immune response, a Texas A&M expert says, giving added protection against Omicron and other variants.
A Texas A&M epidemiologist says the new variant carries concerning mutations, but when it comes to infectiousness and severity, only time will tell.
A discovery by researchers at the Texas A&M College of Medicine could lead to new therapies to prevent the virus from proliferating in the human body.
Experts on vaccines, infectious diseases and global health describe the latest stage of the pandemic.
Students, faculty and staff who voluntarily show proof of vaccination will be eligible for incentive drawings.
The funding will support community-based organizations in implementing COVID-19 vaccine outreach and educational activities.
The team will develop a platform to rapidly prototype and test thermally stable and highly efficient mRNA vaccines.
Researchers aim to answer the question of whether vaccinated individuals can still pass the virus on to unvaccinated people.
Texas A&M virologist Benjamin Neuman discusses how the coronavirus variant could affect the U.S.
The initiative calls on universities to encourage their campus communities to get vaccinated.
A diverse group of Texas A&M researchers will discuss potential solutions to address the pandemic's effects on learning.
Advice from a Texas A&M psychologist.
An update from Texas A&M University.
